A Phase 3 Trial of Bevacizumab in Ovarian Cancer | NEJM
Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer
Overall survival with chemotherapy involving bevacizumab in mcrc... | Download Scientific Diagram
Avastin® (bevacizumab) Clinical Trials | CC Treatment
Bevacizumab and chemotherapy for recurrent glioblastoma | Neurology
Bevacizumab Progression-free Survival Benefit Upheld in AVEREL Trial - The ASCO Post
Avastin® (bevacizumab) Clinical Trials for Ovarian Cancer | HCP
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study - ScienceDirect
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study - The
Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider | SpringerLink
Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium
Improved Survival with Bevacizumab in Advanced Cervical Cancer | NEJM
Overall survival and time to treatment failure for patients eligible... | Download Scientific Diagram
Landmark OS for HCC, updated IMbrave150 data - Medical Conferences
Avastin® (bevacizumab) Clinical Trials | MRCC Treatment
Kaplan-Meier Estimates of Progression-free and Overall Survival,... | Download Scientific Diagram
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3 | British Journal of
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study | Anticancer Research
Avastin® (bevacizumab) Clinical Trials | NSCLC Treatment
IMpower150 Clinical Trial Results | TECENTRIQ® (atezolizumab)
Overall survival according to the addition of bevacizumab to first-line... | Download Scientific Diagram
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study | International Journal of Gynecologic Cancer
Bevacizumab Plus Standard Chemotherapy Improves Survival in Mesothelioma - The ASCO Post
Avastin® (bevacizumab) Clinical Trials | MCRC Treatment
